Skip to main navigation
Skip to search
Skip to main content
Northwestern Scholars Home
Help & FAQ
Home
Experts
Organizations
Research Output
Grants
Core Facilities
Research Data
Search by expertise, name or affiliation
Prot #1199.247: A double blind, randomized, placebo-controlled trial evaluating the efficacy and safety of nintedanib over 52 weeks in patients with Progressive Fibrosing Interstitial Lung Disease (PF-ILD)
Dematte D'Amico, Jane E
(PD/PI)
Medicine, Pulmonary Division
Project
:
Research project
Overview
Project Details
Status
Finished
Effective start/end date
8/16/17
→
2/16/24
Funding
Boehringer Ingelheim Pharmaceuticals, Inc.
((OE) Prot #1199.247)
View all
View less